000 01151 a2200289 4500
005 20250516022319.0
264 0 _c20110404
008 201104s 0 0 eng d
022 _a1532-6535
024 7 _a10.1038/clpt.2010.261
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCornely, O A
245 0 0 _aLack of evidence for exposure-response relationship in the use of posaconazole as prophylaxis against invasive fungal infections.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_cMar 2011
300 _a351-2 p.
_bdigital
500 _aPublication Type: Comment; Letter; Research Support, Non-U.S. Gov't
650 0 4 _aAntifungal Agents
_xadministration & dosage
650 0 4 _aClinical Trials as Topic
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aHumans
650 0 4 _aMycoses
_xprevention & control
650 0 4 _aTreatment Outcome
650 0 4 _aTriazoles
_xadministration & dosage
700 1 _aUllmann, A J
773 0 _tClinical pharmacology and therapeutics
_gvol. 89
_gno. 3
_gp. 351-2
856 4 0 _uhttps://doi.org/10.1038/clpt.2010.261
_zAvailable from publisher's website
999 _c20551002
_d20551002